SCHEMBL18015685

SCHEMBL18015685

Fc1ccc(-c2ccccc2-c2cc(-c3ccccc3-c3cnc(-c4ccccc4)cc3-c3ccccc3)cc(-c3ccccc3-c3cnc(-c4ccccc4)cc3-c3ccccc3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.47
ALDH1A3 P47895 1/20 0.47
ADORA1 P30542 2/20 0.47
MAPT P10636 4/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
PTK2B Q14289 1/20 0.44
ADORA2A P29274 1/20 0.43
SQOR Q9Y6N5 2/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAOB P27338 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18015292 0.90 NPC1 (0.43) TOP1ALDH1A3NPC1RAB9ASMN1; SMN2
SCHEMBL19794359 0.88 LDHA (0.48) TOP1ALDH1A3ADORA1MAPTCYP1A2
SCHEMBL19794360 0.86 TOP1 (0.48) TOP1ALDH1A3ADORA1MAPTCYP1A2
SCHEMBL18015599 0.86 LDHA (0.44) NPC1RAB9ASMN1; SMN2FEN1KDM4E
SCHEMBL18015492 0.86 LDHA (0.44) NPC1RAB9ASMN1; SMN2FEN1KDM4E
SCHEMBL21125093 0.86 LDHA (0.44) NPC1RAB9ASMN1; SMN2FEN1KDM4E
SCHEMBL21202848 0.85 IDO1 (0.44) TOP1NPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL23956184 0.84 LDHA (0.42) MKNK1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL19794464 0.84 LDHA (0.42) MKNK1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL19794460 0.84 NPC1 (0.49) MAPTNPC1RAB9ASMN1; SMN2ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11024815-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-06-01 US disclosed
EP-3254317-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-07-31 EP disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
US-20180026209-A1 Metal Complexes MERCK PATENT GMBH (DE) 2018-01-25 US disclosed
WO-2016124304-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11024815-B2 Metal complexes EXOC4, EXOC3, TIMCC TOP1 3588/4885ALDH1A3 2713/4885ADORA1 933/4885
US-20180026209-A1 Metal Complexes AP3M1, AP2M1, SOD1 TOP1 3428/4885ALDH1A3 1709/4885ADORA1 4700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.